Gunnar Brobert

1.4k total citations
47 papers, 777 citations indexed

About

Gunnar Brobert is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gunnar Brobert has authored 47 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 21 papers in Internal Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gunnar Brobert's work include Atrial Fibrillation Management and Outcomes (26 papers), Venous Thromboembolism Diagnosis and Management (21 papers) and Cardiac Arrhythmias and Treatments (7 papers). Gunnar Brobert is often cited by papers focused on Atrial Fibrillation Management and Outcomes (26 papers), Venous Thromboembolism Diagnosis and Management (21 papers) and Cardiac Arrhythmias and Treatments (7 papers). Gunnar Brobert collaborates with scholars based in Germany, Sweden and United States. Gunnar Brobert's co-authors include Susan S. Jick, Claudia Becker, Christoph Meier, Saga Johansson, Pareen Vora, Bahman Farahmand, Luis A. Garcı́a Rodrı́guez, Panos Vardas, Stefan D. Anker and Maureen Cronin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Gunnar Brobert

46 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gunnar Brobert Germany 16 276 145 99 99 84 47 777
Sophie Rogers Australia 23 256 0.9× 186 1.3× 51 0.5× 190 1.9× 45 0.5× 52 3.0k
Sharyl Martini United States 20 139 0.5× 372 2.6× 84 0.8× 549 5.5× 46 0.5× 53 1.1k
Conor Judge Ireland 15 249 0.9× 51 0.4× 12 0.1× 93 0.9× 150 1.8× 61 993
Yao Hao Teo Singapore 18 165 0.6× 32 0.2× 29 0.3× 116 1.2× 86 1.0× 77 919
Shihong Zhang China 18 251 0.9× 535 3.7× 109 1.1× 910 9.2× 67 0.8× 49 1.8k
Amy Guzik United States 10 90 0.3× 151 1.0× 122 1.2× 455 4.6× 44 0.5× 30 895
Charles J. Moomaw United States 9 424 1.5× 257 1.8× 119 1.2× 377 3.8× 14 0.2× 12 801
Jae‐Kwan Cha South Korea 24 459 1.7× 335 2.3× 259 2.6× 815 8.2× 71 0.8× 120 1.4k
Xiao‐Qing Quan China 15 324 1.2× 42 0.3× 57 0.6× 157 1.6× 21 0.3× 46 873

Countries citing papers authored by Gunnar Brobert

Since Specialization
Citations

This map shows the geographic impact of Gunnar Brobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Brobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Brobert more than expected).

Fields of papers citing papers by Gunnar Brobert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunnar Brobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Brobert. The network helps show where Gunnar Brobert may publish in the future.

Co-authorship network of co-authors of Gunnar Brobert

This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Brobert. A scholar is included among the top collaborators of Gunnar Brobert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Brobert. Gunnar Brobert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Alexander T., Christopher Wallenhorst, Cihan Ay, et al.. (2024). Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study. Thrombosis and Haemostasis. 125(3). 265–277. 3 indexed citations
2.
Ruigómez, Ana, Tania Schink, Ron M. C. Herings, et al.. (2024). Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries. PLoS ONE. 19(3). e0298596–e0298596. 1 indexed citations
3.
Linder, Marie, Anders Ekbom, Gunnar Brobert, et al.. (2024). Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study. Journal of Thrombosis and Thrombolysis. 57(6). 973–983. 1 indexed citations
4.
Swart, Karin M. A., Yanina Balabanova, Gunnar Brobert, et al.. (2023). Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands. Drugs - Real World Outcomes. 10(2). 215–224. 1 indexed citations
5.
Becattini, Cecilia, Marc Carrier, Alexander T. Cohen, et al.. (2023). Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding. SHILAP Revista de lepidopterología. 7(3). e206–e216. 6 indexed citations
6.
Ebert, Natalie, Alice Schneider, Dörte Huscher, et al.. (2023). Incidence of hospital-acquired acute kidney injury and trajectories of glomerular filtration rate in older adults. BMC Nephrology. 24(1). 226–226. 6 indexed citations
9.
Balabanova, Yanina, et al.. (2022). Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom. International Journal of Cardiology. 352. 165–171. 10 indexed citations
10.
Vora, Pareen, Henry Morgan Stewart, Beth Russell, Alex Asiimwe, & Gunnar Brobert. (2022). Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States. International Journal of Clinical Practice. 2022(1). 6707985–6707985. 17 indexed citations
12.
Vora, Pareen, Arto Pietilä, Markku Peltonen, Gunnar Brobert, & Veikko Salomaa. (2020). Thirty-Year Incidence and Mortality Trends in Upper and Lower Gastrointestinal Bleeding in Finland. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
13.
Rodrı́guez, Luis A. Garcı́a, Mari‐Ann Wallander, Leif Friberg, et al.. (2020). Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert Opinion on Drug Safety. 19(11). 1513–1520. 4 indexed citations
14.
Rodrı́guez, Luis A. Garcı́a, Mar Martín‐Pérez, Pareen Vora, et al.. (2019). Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK. BMJ Open. 9(9). e031341–e031341. 27 indexed citations
17.
Vora, Pareen, Montse Soriano‐Gabarró, Kiliana Suzart‐Woischnik, & Gunnar Brobert. (2016). Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies. Patient Preference and Adherence. Volume 10. 1657–1665. 10 indexed citations
18.
Becker, Claudia, Gunnar Brobert, Per Almqvist, et al.. (2007). Migraine and the Risk of Stroke, TIA, or Death in the UK (CME). Headache The Journal of Head and Face Pain. 47(10). 1374–1384. 35 indexed citations
19.
Zammit, Stanley, Finn Rasmussen, Bahman Farahmand, et al.. (2007). Height and body mass index in young adulthood and risk of schizophrenia: a longitudinal study of 1 347 520 Swedish men. Acta Psychiatrica Scandinavica. 116(5). 378–385. 45 indexed citations
20.
Farahmand, Bahman, Ulf Hållmarker, Gunnar Brobert, & Anders Ahlbom. (2006). Acute mortality during long‐distance ski races (Vasaloppet). Scandinavian Journal of Medicine and Science in Sports. 17(4). 356–361. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026